We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to $104.00 in a note issued to investors on Tuesday,Benzinga reports.

it appears that whales have been targeting a price range from $70.0 to $125.0 for DexCom over the last 3 months. Insights into Volume & Open Interest In today's trading context, the average open ...

Citi raised the firm’s price target on DexCom (DXCM) to $104 from $101 and keeps a Buy rating on the shares. The firm adjusted medical ...

DexCom Inc. closed 51.77% below its 52-week high of $142.00, which the company achieved on March 26th.

DexCom Inc. closed 50.22% short of its 52-week high of $142.00, which the company achieved on March 26th.

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new geographies.

Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...

Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S. DexCom (NasdaqGS:DXCM) recently received a warning letter ...